Marinus Pharmaceuticals Inc Revenue per Employee (MRNS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Marinus Pharmaceuticals Inc   (NASDAQ: MRNS)
 

Marinus Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 16.39% in the third quarter 2024, year on year to cumulative value of $31 million, Marinus Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 190,703, this is below the company average.
Within the Healthcare sector Employees of 252 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1977, from total ranking in previous quarter at 2046. Marinus Pharmaceuticals Inc has 165 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MRNS Revenue per Employee (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Revenue Change 16.39 % 32.48 % -26.02 % 0.39 % 213.59 %
Sales per Employee (TTM) $ 190,703 183,412 171,442 187,812 187,642
MRNS's Total Ranking # 1977 # 2046 # 0 # 0 #
Seq. Revenue Change 6.02 % 4.91 % 6.8 % -2.02 % 20.67 %

MRNS Company Profile >> Back to MRNS Efficiency Comparisons >> Compare MRNS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 114
Healthcare Sector # 253
Overall Market # 1977

Revenue per Employee Statistics
High Average Low
$ 265,664 $ 211,750 $ 128,950
(Sep 30 2024)   (Dec 31 2021)



Financial Statements
Marinus Pharmaceuticals Inc 's Revenue MRQ $ 9 Millions Visit MRNS's Income Statement
Marinus Pharmaceuticals Inc 's Revenues TTM $ 31 Millions Visit MRNS's aggregate revenue growth
What are MRNS's Sales? Visit MRNS's Sales by Segment




Other Ratios
Marinus Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MRNS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MRNS's Competitors
Revenue per Employee for MRNS's Suppliers
Revenue per Employee for MRNS's Customers

You may also want to know
MRNS's Sales Growth Rates MRNS's Pe Price to earnings ratio MRNS's Receivables Turnover Ratio MRNS's Stock Quote
MRNS's Net Income Growth Rates MRNS's Ps Price to Sales ratio MRNS's Sales per Employee MRNS's Asset Turnover Ratio
MRNS's Net Margin MRNS's Pb Price to Book ratio MRNS's Financial Strength Ratios MRNS's Dividend Payout Ratio
Date modified: 2026-08-29T17:19:29+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2024Number of Employees Sep 30 2024
Healthlynked Corp  332,063.40 $ 3.321  Million 10 
Yunhong Green Cti Ltd   331,538.46 $ 17.240  Million 52 
Atricure Inc   330,702.22 $ 446.448  Million 1,350 
Conmed Corporation  330,286.41 $ 1,288.117  Million 3,900 
23andme Holding Co  329,706.19 $ 191.889  Million 582 
Cue Biopharma Inc   328,689.66 $ 9.532  Million 29 
Glaukos Corp  328,053.02 $ 358.890  Million 1,094 
Lensar Inc   325,786.67 $ 48.868  Million 150 
Surmodics Inc   324,107.97 $ 126.078  Million 389 
C4 Therapeutics Inc   323,730.77 $ 33.668  Million 104 
Lemaitre Vascular Inc   322,723.66 $ 211.384  Million 655 
Twist Bioscience Corporation  319,687.44 $ 312.974  Million 979 
Nexgel Inc   317,894.74 $ 6.040  Million 19 
Repligen Corp  316,756.50 $ 633.513  Million 2,000 
Tango Therapeutics Inc   316,671.53 $ 43.384  Million 137 
Amneal Pharmaceuticals Inc   315,320.59 $ 2,680.225  Million 8,500 
Innovage Holding Corp   314,604.80 $ 786.512  Million 2,500 
Opko Health Inc   312,707.25 $ 711.409  Million 2,275 
Orthopediatrics Corp  312,601.33 $ 188.186  Million 602 
Immucell Corporation  310,046.82 $ 22.633  Million 73 
Lifeward ltd   308,666.67 $ 25.002  Million 81 
Tela Bio Inc   307,224.77 $ 66.975  Million 218 
Cryoport inc   306,386.18 $ 226.113  Million 738 
Pediatrix Medical Group Inc   306,178.18 $ 2,006.998  Million 6,555 
Logicmark Inc  305,409.45 $ 10.079  Million 33 
Myriad Genetics Inc   305,037.04 $ 823.600  Million 2,700 
Ge Healthcare Technologies Inc   303,685.19 $ 16,399.000  Million 54,000 
Urogen Pharma Ltd   302,243.99 $ 87.953  Million 291 
Sage Therapeutics Inc   301,410.76 $ 106.398  Million 353 
Talkspace Inc   300,757.53 $ 179.853  Million 598 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.